neurodegenerative disease
Study explores speech as marker in rare neurodegenerative disease
April 27, 2026Research and Development SynaptixBio, neurodegenerative disease
SynaptixBio has highlighted the potential of speech analysis as a non-invasive way to track disease progression in neurodegenerative conditions, as …
EVerZom receives €3m funding from French government to industrialise exosome technology
June 18, 2025Research and Development BpiFfrance, Corporate, Crohn’s disease, EVerZom, France 2030, French government, age-related disorders, exosome therapy, neurodegenerative disease
EVerZom, a French biopharma company focused on exosome-based therapies, has announced it has received €3m in funding as part of …
Roche advances treatment for Parkinson’s disease
June 16, 2025Research and Development Neurology, Parkinson's disease, Roche, clinical trials, neurodegenerative disease
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, an investigational therapy for Parkinson’s …
Chiesi partners with Key2Brain to develop therapies for rare neurodegenerative diseases
June 12, 2025Manufacturing and Production, Mergers and Acquisitions, Research and Development Chiesi Group, Key2Brain, Neurology, Rare Diseases, lysosomal storage disorders, neurodegenerative disease, partnership, ultra-rare disease
Italian biopharma, Chiesi Group, and Key2Brain, a Swedish biotech, have agreed to advance the development of two blood-brain barrier (BBB)-crossing …
Eisai withdraws application for neurodegenerative-disease drug in Japan
March 22, 2016Manufacturing and Production, Research and Development Eisai, mecobalamin, neurodegenerative disease
Pharma major Eisai (TYO: 4523) on Tuesday said the Japanese regulators have stalled the approval of its drug to treat …
